Evidence map›Paper›PMID 26194692›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2015

Environmental survival of vancomycin-sensitive ampicillin-resistant Enterococcus faecium (AREfm).

J H T Wagenvoort, E I G B De Brauwer, R J R Penders, C J van der Linden, R J Willems, J Top, M J Bonten

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Interactions between commensalFEMS microbes · 2024
    Article
  2. Enterococcal Membrane Vesicles as Vaccine Candidates.International journal of molecular sciences · 2023
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Co-diversification ofFrontiers in microbiology · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

J H T WagenvoortDepartment of Medical Microbiology, Atrium Medical Centre Parkstad, Postbox 4446, 6401 CX, Heerlen, The Netherlands, medische.microbiologie@atriummc.nl.
E I G B De Brauwer
R J R Penders
C J van der Linden
R J Willems
J Top
M J Bonten
Atrium Medical (Australia) · AUUniversity Medical Center Utrecht · NLAtrium Medisch Centrum Parkstad · NLUtrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ampicillin-resistant Enterococcus faecium (AREfm) has gained increased footholds in many hospital intensive care units (ICUs) and belongs to specific hospital-adapted E. faecium sub-populations. Three AREfm strains survived in an in vitro survival setting for approximately 5.5 years. These findings have important consequences for the epidemiology of AREfm in hospital settings and stress the importance of maintaining a good level of hospital hygiene.

Indexed as

AmpicillinAmpicillin ResistanceAnti-Bacterial AgentsCross InfectionDrug Resistance, Multiple, BacterialEnterococcus faeciumGram-Positive Bacterial InfectionsHospitalsHumansMicrobial Sensitivity TestsVancomycinAmpicillinAnti-Bacterial AgentsVancomycin

Identifiers

PMID26194692
OpenAlexW1595195735

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.